Search Tag: breast screening

IMAGING Management

ESOR Foundation Courses 2023 - Breast Imaging

2023 26 Apr

Find ESOR on Social media   Read more

Women's Health

Hologic Ranked #1 for Mammography System Performance and Customer Satisfaction

2022 01 Dec

Global Leader in Women’s Health Recognized with Three IMV ServiceTrak™ Awards for Mammography During RSNA 2022 Hologic , Inc., an innovative medical technology company primarily focused on improving women’s health, swept the 2022 IMV ServiceTrak™ Awards for Mammography, taking home awards for Best Service, Best Customer Satisfaction and... Read more

Women's Health

Study Finds Women with Benign Breast Disease Face Long-Term Risk of Breast Cancer

2022 25 Nov

A population-based study, involving 7778,306 women aged 50-69 years, assesses their risk of breast cancer after participating in at least one mammographic screening. Researchers compared the incident rates of women diagnosed with and without benign breast cancer.   Women involved in the study had taken part in a breast screening between 1996 and... Read more

Women's Health

Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022

2022 25 Nov

New Affirm® Contrast Biopsy Technology Included in the Screening, Diagnosis, Treatment and Monitoring Solutions on Display Hologic , will exhibit its extensive portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec.1. Among the... Read more

Women's Health

When Should Women Start Breast Cancer Screening?

2022 20 Sep

Although breast cancer screening cannot prevent breast cancer, it remains an important public health intervention. The goal is to detect cancer early so it can be treated more successfully.   Although there remains a huge benefit to screening in reducing breastcancer-related deaths, public health experts also acknowledge there are risks and harmful... Read more

Women's Health

Refining Breast Cancer Screening to Increase Effectiveness

2022 01 Aug

Cancer is a disease that, if left untreated, can progress and spread rapidly and cause death. Breast cancer has a diverse range of pathological entities and can incorporate indolent to aggressive legions. It can have varying histological patterns, clinical presentations, treatment responses and outcomes. Timely screening is essential, and intervening... Read more

Women's Health

Racial Disparities in Breast Cancer

2022 30 Jun

New findings published in Cancer Epidemiology Biomarkers & Prevent show significant differences in the accuracy of diagnostic mammograms across racial and ethnic groups, with variation observed in several measures of diagnostic performance.  Several studies have already established that racial disparities exist in breast cancer. Multiple socioeconomic... Read more

Women's Health

NICE Endorses Magnetic Marker Liquid Probe for Breast Cancer Metastasis

2022 19 May

The UK National Institute for Health and Care Excellence (NICE) now endorses the use of Magtrace and Sentimag magnetic marker liquids to locate sentinel lymph nodes in women with breast cancer in a new draft guidance.   Sentinel lymph nodes are the first lymph nodes that a primary tumour can drain. When the tracer is injected into a tumour, tracer... Read more

Women's Health

AI Catches What Radiologists Miss on Breast Screening

2022 16 May

A large German study found that AI can accurately detect and localise breast cancers on screening exams missed by radiologists, which in turn can reduce the frequency of cancers between screenings (usually 24 months).   Many breast cancers are clinically detected due the onset of symptoms during the interval between breasts screenings. Often... Read more

Women's Health

Flatiron Data Supports Using Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

2022 09 May

This Pfizer-sponsored study used de-identified data derived from the Flatiron Health Analytic Database in a retrospective observational study to demonstrate palbociclib (PAL) combined with an aromatase inhibitor (AI) is an effective first-line therapy for treating metastatic breast cancer.   Hormone receptor-positive/human epidermal growth factor... Read more